| |
|
|
| |
False Claims Act
Update & Alert |
|
| |
Taxpayers
Against Fraud Education Fund | Washington, D.C. |
WWW.TAF.ORG
November 10, 2009 |
|
| |
. |
|
|
. |
| |
|
n
TAF Home Page
n
Previous Newsletters
n
Email editor
|
Please take a moment to forward this FREE
electronic newsletter to others who might be interested! |
|
 Guidant
to Pay $296 million
Guidant's parent company,
Boston Scientific,
has made an "agreement in principal" to pay the U.S. Government
$296 million to settle a case involving defective defibrillators
billed to Medicare and Medicaid.
This case is separate and apart
from an investigation, underway in Boston, involving suspected
illegal marketing practices associated with
defibrillators and other heart-rhythm devices.
>>
To read more
|
|
|
|
 Omnicare
and Ivax Pay $112 Million to Settle Kickback Charges
DoJ has announced a $112 million settlement with
Omnicare and IVAX
Pharmaceuticals to resolve multiple
whistleblower lawsuits, The FCA lawsuits allege
Johnson & Johnson paid
kickbacks to Omnicare and
two nursing home chains
so doctors would prescribe Risperdal to patients for which it was an
improper medication. In addition,
IVAX
paid $8 million
to Omnicare to facilitate a drug-switching scheme. Finally,
Omnicare, and two nursing home chains conspired to have Omnicare pay
$50 million in order to keep a pharmacy services contact. >>
To read more |
|
 Defective
Bunker Buster Fuzes
DoJ
has filed
a lawsuit against Kaman Dayron Inc., alleging the defense contractor
violated the False Claims Act by knowingly substituting non-conforming
parts in fuzes supplied to the military for use in "bunker buster"
bombs. The nonconforming fuzes could cause the bombs to fire prematurely.
>>
To read more |
|
 Abbott
Faces Depakote Probe
Abbott Labs, already under the gun
in one False Claims Act lawsuit joined by DoJ, is now under
investigation
for illegal
marketing of Depakote, a drug used to treat bipolar disorder,
seizures and migraines.
The U.S. Attorney in the Western District of Virginia is
handling the probe.
>>
To read more |
|
 SEC
Whistleblower Bill on Horizon?
The House Financial Services Committee has reported out H.R. 3817, the
Investor Protection Act, introduced by Congressman Paul E. Kanjorski
(D-PA). The bill would, among other things, strengthen the SEC's
whistleblower bounty program
by creating stronger incentives for individuals to come forward to
report illegal securities market activities.
>>
To read more |
|
|
|
|
..... |
| |
|
|